Medical Oncolody Division, Igea SpA, 80013 Naples, Italy.
Department of Electrical Engineering and Information Technologies, Università degli Studi di Napoli Federico II, 80125 Naples, Italy.
Curr Oncol. 2022 Mar 13;29(3):1947-1966. doi: 10.3390/curroncol29030159.
:The purpose of this study was to discriminate between benign and malignant breast lesions through several classifiers using, as predictors, radiomic metrics extracted from CEM and DCE-MRI images. In order to optimize the analysis, balancing and feature selection procedures were performed. : Fifty-four patients with 79 histo-pathologically proven breast lesions (48 malignant lesions and 31 benign lesions) underwent both CEM and DCE-MRI. The lesions were retrospectively analyzed with radiomic and artificial intelligence approaches. Forty-eight textural metrics were extracted, and univariate and multivariate analyses were performed: non-parametric statistical test, receiver operating characteristic (ROC) and machine learning classifiers. : Considering the single metrics extracted from CEM, the best predictors were KURTOSIS (area under ROC curve (AUC) = 0.71) and SKEWNESS (AUC = 0.71) calculated on late MLO view. Considering the features calculated from DCE-MRI, the best predictors were RANGE (AUC = 0.72), ENERGY (AUC = 0.72), ENTROPY (AUC = 0.70) and GLN (gray-level nonuniformity) of the gray-level run-length matrix (AUC = 0.72). Considering the analysis with classifiers and an unbalanced dataset, no significant results were obtained. After the balancing and feature selection procedures, higher values of accuracy, specificity and AUC were reached. The best performance was obtained considering 18 robust features among all metrics derived from CEM and DCE-MRI, using a linear discriminant analysis (accuracy of 0.84 and AUC = 0.88). Classifiers, adjusted with adaptive synthetic sampling and feature selection, allowed for increased diagnostic performance of CEM and DCE-MRI in the differentiation between benign and malignant lesions.
本研究旨在通过使用 CEM 和 DCE-MRI 图像的放射组学指标作为预测因子,通过几种分类器来区分良性和恶性乳腺病变。为了优化分析,进行了平衡和特征选择过程。
54 名患者(48 名恶性病变和 31 名良性病变)进行了 CEM 和 DCE-MRI 检查,这些患者的 79 个组织病理学证实的乳腺病变被回顾性地进行了放射组学和人工智能分析。提取了 48 个纹理指标,并进行了单变量和多变量分析:非参数统计检验、接收者操作特征(ROC)和机器学习分类器。
考虑到从 CEM 提取的单一指标,最佳预测因子是峰度(ROC 曲线下面积(AUC)= 0.71)和偏度(AUC = 0.71),在 MLO 视图晚期计算。考虑到从 DCE-MRI 计算的特征,最佳预测因子是范围(AUC = 0.72)、能量(AUC = 0.72)、熵(AUC = 0.70)和 GLN(灰度不均匀性)灰度游程矩阵(AUC = 0.72)。考虑到不平衡数据集的分类器分析,没有得到显著的结果。在平衡和特征选择过程后,达到了更高的准确性、特异性和 AUC 值。考虑到从 CEM 和 DCE-MRI 获得的所有指标中选择 18 个稳健特征,使用线性判别分析(准确性为 0.84 和 AUC = 0.88),获得了最佳性能。
经自适应合成采样和特征选择调整的分类器可提高 CEM 和 DCE-MRI 在良性和恶性病变鉴别中的诊断性能。